Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.83EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.83EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.83ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.83ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.310EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.310EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.310ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.310ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.310EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.310EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.310ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.310ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.362.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.362.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.362.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.362.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.362.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.362.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.362.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.362.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.162EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.162EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.162ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.162ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.162EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.162EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.162ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.162ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Y.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Y.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Y.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
Y.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Y.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Y.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Y.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Y.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.86EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.86ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.86ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.86EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.86EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.86ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.86ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.154EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.154EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.154ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.154ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.154EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.154EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used